Analysts show optimism for Novavax's decreasing losses despi...
Analysts show optimism for Novavax's decreasing losses despite predicted revenue drop. However, they also lowered their revenue estimates, suggesting Novavax may underperform the broader industry. They believe the company's intrinsic value is improving, despite the pessimistic revenue outlook.
Novavax, Inc. (NASDAQ:NVAX) Analysts Are Pretty Bullish On The Stock After Recent Results
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment